打破障碍:尼普利辛在慢性心脏病综合征中的抑制
1Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, FL 32610, United States.
World journal of cardiology
|July 31, 2025
概括
尼普利辛的抑制是心力衰竭 (HF) 的关键. 本综述探讨了其在患有慢性病 (CKD) 或末期病 (ESKD) 的患者中的应用,解决了有效性和安全性的问题.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 尼普利辛抑制是心力衰竭 (HF) 的基石疗法.
- 患有慢性病 (CKD) 和末期病 (ESKD) 的患者经常患有HF,这种情况被称为心脏综合征.
- 心脏病综合征与增加住院和死亡率有关.
研究的目的:
- 审查在HF患者中抑制 neprilysin 的证据.
- 讨论 neprilysin 抑制在同时患有 CKD 或 ESKD 的患者中的应用.
- 为了解决关于普里里素抑制剂在晚期病中的有效性和安全性的不确定性.
主要方法:
- 对现有关于抑制HF的普里利辛研究的文献综述.
- 对患有CKD和ESKD的HF患者的数据分析.
- 讨论临床影响和未来的研究方向.
主要成果:
- 尼普利辛抑制剂已经证明在HF管理中的有效性.
- 目前关于在晚期CKD/ESKD中使用 neprilysin 抑制剂的数据有限.
- 潜在的益处和安全问题需要进一步调查.
结论:
- 尼普利辛的抑制是治疗高血压的重要治疗方法.
- 需要进行进一步的研究,以确定 neprilysin 抑制剂在晚期CKD或ESKD患者中的安全性和有效性.
- 了解心综合征对于优化病患者的高血压治疗至关重要.
更多相关视频
08:21A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
5.0K
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.8K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
01:22Heart Failure Drugs: Diuretics
495
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
495
01:25Antihypertensive Drugs: Direct Renin Inhibitors
827
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
827
01:11Renal Failure: Dose Adjustments
161
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
161
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
888
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
888
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57